Harvard Bioscience Company Profile (NASDAQ:HBIO)

About Harvard Bioscience (NASDAQ:HBIO)

Harvard Bioscience logoHarvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company's products consist of instruments, consumables and systems that are made up of various individual products.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:HBIO
  • CUSIP: 41690610
  • Web: www.harvardbioscience.com
Capitalization:
  • Market Cap: $88.28 million
  • Outstanding Shares: 34,618,000
Average Prices:
  • 50 Day Moving Avg: $2.55
  • 200 Day Moving Avg: $2.65
  • 52 Week Range: $2.25 - $3.30
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 53.00
  • P/E Growth: 1.67
Sales & Book Value:
  • Annual Revenue: $101.71 million
  • Price / Sales: 0.90
  • Book Value: $2.10 per share
  • Price / Book: 1.26
Profitability:
  • EBIDTA: $2.53 million
  • Net Margins: -4.66%
  • Return on Equity: 2.41%
  • Return on Assets: 1.62%
Debt:
  • Debt-to-Equity Ratio: 0.15%
  • Current Ratio: 3.21%
  • Quick Ratio: 1.77%
Misc:
  • Average Volume: 56,967 shs.
  • Beta: 1.06
  • Short Ratio: 8.54
 
Frequently Asked Questions for Harvard Bioscience (NASDAQ:HBIO)

What is Harvard Bioscience's stock symbol?

Harvard Bioscience trades on the NASDAQ under the ticker symbol "HBIO."

How were Harvard Bioscience's earnings last quarter?

Harvard Bioscience, Inc. (NASDAQ:HBIO) posted its earnings results on Thursday, July, 28th. The company reported $0.03 EPS for the quarter, meeting the Zacks' consensus estimate of $0.03. The company earned $26.10 million during the quarter, compared to analysts' expectations of $26.60 million. Harvard Bioscience had a negative net margin of 4.66% and a positive return on equity of 2.41%. View Harvard Bioscience's Earnings History.

Where is Harvard Bioscience's stock going? Where will Harvard Bioscience's stock price be in 2017?

2 brokerages have issued 1 year price targets for Harvard Bioscience's stock. Their predictions range from $5.50 to $6.00. On average, they expect Harvard Bioscience's share price to reach $5.75 in the next year. View Analyst Ratings for Harvard Bioscience.

Who are some of Harvard Bioscience's key competitors?

Who are Harvard Bioscience's key executives?

Harvard Bioscience's management team includes the folowing people:

  • James W. Green, Chairman of the Board
  • Jeffrey A Duchemin, President, Chief Executive Officer, Director
  • Robert E Gagnon, Chief Financial Officer
  • Yong Sun, Vice President - Strategic Marketing and Business Development
  • David M. Green, Director
  • Neal J. Harte, Independent Director
  • John F. Kennedy, Independent Director
  • Bertrand Loy, Independent Director
  • George Uveges, Independent Director

Who owns Harvard Bioscience stock?

Harvard Bioscience's stock is owned by many different of retail and institutional investors. Top institutional investors include Acadian Asset Management LLC (2.12%) and ICM Asset Management Inc. WA (0.32%). Company insiders that own Harvard Bioscience stock include David Green, Earl R Lewis, George Uveges, James W Green, Jeffrey Duchemin, John F Kennedy and Robert E Gagnon. View Institutional Ownership Trends for Harvard Bioscience.

Who sold Harvard Bioscience stock? Who is selling Harvard Bioscience stock?

Harvard Bioscience's stock was sold by a variety of institutional investors in the last quarter, including ICM Asset Management Inc. WA and Acadian Asset Management LLC. Company insiders that have sold Harvard Bioscience stock in the last year include David Green and Earl R Lewis. View Insider Buying and Selling for Harvard Bioscience.

How do I buy Harvard Bioscience stock?

Shares of Harvard Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Harvard Bioscience's stock price today?

One share of Harvard Bioscience stock can currently be purchased for approximately $2.65.


MarketBeat Community Rating for Harvard Bioscience (NASDAQ HBIO)
Community Ranking:  1.7 out of 5 ()
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  112
MarketBeat's community ratings are surveys of what our community members think about Harvard Bioscience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Harvard Bioscience (NASDAQ:HBIO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.75 (116.98% upside)

Analysts' Ratings History for Harvard Bioscience (NASDAQ:HBIO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/21/2016Benchmark Co.Set Price TargetBuy$6.00N/AView Rating Details
11/17/2016Singular ResearchInitiated CoverageBuy$5.50N/AView Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for Harvard Bioscience (NASDAQ:HBIO)
Earnings by Quarter for Harvard Bioscience (NASDAQ:HBIO)
Earnings History by Quarter for Harvard Bioscience (NASDAQ HBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/9/2017Q4 2016$0.04$0.01$26.90 million$26.42 millionViewListenView Earnings Details
10/27/2016Q3$0.01$0.01$26.00 million$25.01 millionViewListenView Earnings Details
7/28/2016Q2$0.03$0.03$26.60 million$26.10 millionViewListenView Earnings Details
5/12/2016Q1$0.02$0.05$26.00 million$27.00 millionViewListenView Earnings Details
4/29/2016Q4$0.03$0.03$28.37 millionViewN/AView Earnings Details
10/29/2015Q315$0.05$0.03$27.01 million$25.70 millionViewListenView Earnings Details
7/30/2015Q215$0.04$0.05$26.60 million$28.80 millionViewListenView Earnings Details
4/30/2015Q414$0.05$0.01$27.15 million$25.80 millionViewListenView Earnings Details
2/26/2015Q314$0.09$0.08$29.30 million$30.40 millionViewN/AView Earnings Details
10/30/2014Q214$0.06$0.05$25.46 million$25.40 millionViewN/AView Earnings Details
7/31/2014Q2$0.05$0.05$26.00 million$26.96 millionViewN/AView Earnings Details
2/27/2014Q413($0.02)$0.05$28.20 million$27.90 millionViewN/AView Earnings Details
10/31/2013Q313$0.01$0.05$26.10 million$25.10 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.08$28.30 million$26.10 millionViewN/AView Earnings Details
11/1/2012Q312$0.08$26.40 million$26.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Harvard Bioscience (NASDAQ:HBIO)
Current Year EPS Consensus Estimate: $0.06 EPS
Next Year EPS Consensus Estimate: $0.05 EPS

Dividends

Dividend History for Harvard Bioscience (NASDAQ:HBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Harvard Bioscience (NASDAQ:HBIO)
Insider Ownership Percentage: 8.80%
Institutional Ownership Percentage: 61.98%
Insider Trades by Quarter for Harvard Bioscience (NASDAQ:HBIO)
Institutional Ownership by Quarter for Harvard Bioscience (NASDAQ:HBIO)
Insider Trades by Quarter for Harvard Bioscience (NASDAQ:HBIO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/12/2017Jeffrey DucheminCEOBuy22,000$2.76$60,720.00View SEC Filing  
6/8/2017James W. GreenDirectorBuy7,712$2.55$19,665.60View SEC Filing  
5/26/2017Robert E. GagnonCFOBuy1,000$2.33$2,330.00View SEC Filing  
5/25/2017Earl R. LewisDirectorBuy12,238$2.35$28,759.30View SEC Filing  
5/24/2017Earl R. LewisDirectorBuy10,000$2.38$23,800.00View SEC Filing  
2/7/2017David GreenDirectorSell3,239$3.25$10,526.75View SEC Filing  
2/6/2017David GreenDirectorSell1,288$3.25$4,186.00View SEC Filing  
12/6/2016Earl R. LewisDirectorSell23,088$2.42$55,872.96View SEC Filing  
11/3/2016Jeffrey DucheminCEOBuy15,000$2.42$36,300.00View SEC Filing  
11/3/2016Robert E. GagnonCFOBuy25,000$2.34$58,500.00View SEC Filing  
12/10/2015Jeffrey DucheminCEOBuy10,000$3.37$33,700.00View SEC Filing  
12/3/2015George UvegesDirectorBuy3,000$3.32$9,960.00View SEC Filing  
11/9/2015Robert E GagnonCFOBuy3,000$3.08$9,240.00View SEC Filing  
9/2/2015Jeffrey DucheminCEOBuy2,000$4.41$8,820.00View SEC Filing  
9/1/2015John F KennedyDirectorBuy2,000$4.33$8,660.00View SEC Filing  
7/17/2015David GreenDirectorSell17,103$5.26$89,961.78View SEC Filing  
7/14/2015David GreenDirectorSell51,597$5.28$272,432.16View SEC Filing  
4/23/2015David GreenDirectorSell118,500$6.03$714,555.00View SEC Filing  
4/22/2015David GreenDirectorSell123,997$6.23$772,501.31View SEC Filing  
4/17/2015David GreenDirectorSell42,503$6.55$278,394.65View SEC Filing  
4/14/2015David GreenDirectorSell80,168$6.61$529,910.48View SEC Filing  
2/9/2015David GreenDirectorSell48,712$5.25$255,738.00View SEC Filing  
12/30/2014David GreenDirectorSell16,173$5.25$84,908.25View SEC Filing  
12/29/2014David GreenDirectorSell100,167$5.25$525,876.75View SEC Filing  
12/22/2014David GreenDirectorSell80,202$5.02$402,614.04View SEC Filing  
11/19/2014David GreenDirectorSell10,000$4.95$49,500.00View SEC Filing  
10/31/2014David GreenDirectorSell117,654$4.97$584,740.38View SEC Filing  
6/16/2014Robert E GagnonCFOBuy5,000$3.86$19,300.00View SEC Filing  
5/29/2014Neal J HarteDirectorSell12,317$3.82$47,050.94View SEC Filing  
4/9/2014David GreenDirectorSell27,540$4.47$123,103.80View SEC Filing  
4/8/2014David GreenDirectorSell66,090$4.48$296,083.20View SEC Filing  
4/3/2014David GreenDirectorSell63,501$4.63$294,009.63View SEC Filing  
8/27/2013Chane GrazianoMajor ShareholderBuy60,000$5.00$300,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Harvard Bioscience (NASDAQ:HBIO)
Latest Headlines for Harvard Bioscience (NASDAQ:HBIO)
Source:
DateHeadline
americanbankingnews.com logoHarvard Bioscience, Inc. (HBIO) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - July 21 at 9:56 PM
finance.yahoo.com logoHarvard Bioscience Schedules Second Quarter 2017 Conference Call for July 27 at 4:30 PM ET
finance.yahoo.com - July 18 at 9:19 PM
feeds.benzinga.com logoHarvard Bioscience Schedules Second Quarter 2017 Conference Call for July 27 at 4:30 PM ET
feeds.benzinga.com - July 18 at 5:57 PM
americanbankingnews.com logoZacks Investment Research Lowers Harvard Bioscience, Inc. (NASDAQ:HBIO) to Hold
www.americanbankingnews.com - July 16 at 12:59 PM
americanbankingnews.com logoHarvard Bioscience, Inc. (NASDAQ:HBIO) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - July 12 at 10:56 PM
prnewswire.com logoBiopharmaceutical Companies to Remain the Largest End-user of Chromatography Resins Globally
www.prnewswire.com - July 11 at 5:26 AM
finance.yahoo.com logoETFs with exposure to Harvard Bioscience, Inc. : July 5, 2017
finance.yahoo.com - July 5 at 7:58 PM
americanbankingnews.com logoInsider Buying: Harvard Bioscience, Inc. (HBIO) CEO Acquires 22,000 Shares of Stock
www.americanbankingnews.com - June 13 at 8:38 PM
americanbankingnews.com logoJames W. Green Acquires 7,712 Shares of Harvard Bioscience, Inc. (HBIO) Stock
www.americanbankingnews.com - June 9 at 8:44 PM
finance.yahoo.com logoETFs with exposure to Harvard Bioscience, Inc. : June 8, 2017
finance.yahoo.com - June 8 at 6:37 PM
streetinsider.com logoHarvard Bioscience (HBIO) Names James Green as Chairman
www.streetinsider.com - June 7 at 10:12 PM
finance.yahoo.com logoHarvard Bioscience Elects James Green as Chairman of Board of Directors
finance.yahoo.com - June 7 at 5:09 PM
americanbankingnews.com logoValuEngine Downgrades Harvard Bioscience, Inc. (HBIO) to Sell
www.americanbankingnews.com - June 4 at 1:04 PM
americanbankingnews.com logoEarl R. Lewis Buys 12,238 Shares of Harvard Bioscience, Inc. (HBIO) Stock
www.americanbankingnews.com - May 31 at 7:28 AM
americanbankingnews.com logoHarvard Bioscience, Inc. (HBIO) Director Earl R. Lewis Buys 10,000 Shares
www.americanbankingnews.com - May 25 at 8:28 PM
finance.yahoo.com logoETFs with exposure to Harvard Bioscience, Inc. : May 11, 2017
finance.yahoo.com - May 11 at 6:12 PM
finance.yahoo.com logoHarvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 12:48 PM
americanbankingnews.com logoHarvard Bioscience (HBIO) Earns Daily News Sentiment Rating of 0.57
www.americanbankingnews.com - May 3 at 10:30 AM
americanbankingnews.com logoHarvard Bioscience (HBIO) Earning Favorable Press Coverage, Report Shows
www.americanbankingnews.com - April 30 at 10:51 AM
americanbankingnews.com logoHarvard Bioscience, Inc. (HBIO) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 29 at 1:13 AM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 27-Apr-17 8:30pm GMT
finance.yahoo.com - April 28 at 6:36 PM
marketbeat.com logoHarvard Bioscience reports 1Q loss
marketbeat.com - April 27 at 5:45 PM
finance.yahoo.com logoInvestor Network: Harvard Bioscience, Inc. to Host Earnings Call
finance.yahoo.com - April 27 at 3:33 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Very Likely to Impact Harvard Bioscience (HBIO) Share Price
www.americanbankingnews.com - April 26 at 9:24 PM
finance.yahoo.com logoHarvard Bioscience Schedules First Quarter 2017 Conference Call for April 27 at 4:30 PM ET
finance.yahoo.com - April 19 at 8:43 PM
americanbankingnews.com logoHarvard Bioscience (HBIO) Earning Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 13 at 11:16 AM
finance.yahoo.com logoETFs with exposure to Harvard Bioscience, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 5:30 PM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 17 at 5:51 PM
seekingalpha.com logoHarvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 10 at 10:17 AM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 9-Mar-17 9:30pm GMT
finance.yahoo.com - March 10 at 10:17 AM
biz.yahoo.com logoQ4 2016 Harvard Bioscience Inc Earnings Release - After Market Close
us.rd.yahoo.com - March 9 at 6:01 PM
us.rd.yahoo.com logoHarvard Bioscience Reports Fourth Quarter and Year-End 2016 Results and 2017 Financial Guidance
us.rd.yahoo.com - March 9 at 6:01 PM
americanbankingnews.com logoHarvard Bioscience, Inc. (HBIO) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - March 8 at 9:19 AM
finance.yahoo.com logoHarvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET
finance.yahoo.com - February 23 at 5:37 PM
seekingalpha.com logoHarvard Bioscience, Inc. (HBIO) Presents At Singular Research "Uncovered Values & Special Situation Web Call"
seekingalpha.com - December 20 at 10:54 AM
finance.yahoo.com logoCoverage initiated on Harvard Biosci by Singular Research
finance.yahoo.com - November 17 at 4:54 PM
finance.yahoo.com logoHARVARD BIOSCIENCE INC Financials
finance.yahoo.com - November 10 at 4:46 PM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 27-Oct-16 8:30pm GMT
finance.yahoo.com - October 29 at 8:17 AM
biz.yahoo.com logoHarvard Bioscience Inc Earnings Call scheduled for 4:30 pm ET today
biz.yahoo.com - October 27 at 5:26 PM
biz.yahoo.com logoQ3 2016 Harvard Bioscience Inc Earnings Release - After Market Close
biz.yahoo.com - October 27 at 10:07 AM
finance.yahoo.com logoHarvard Bioscience (HBIO): Moving Average Crossover Alert
finance.yahoo.com - August 29 at 5:16 PM
bizjournals.com logoEXCLUSIVE: UW president lays out vision for Global Innovation Exchange
www.bizjournals.com - August 17 at 5:36 PM
finance.yahoo.com logo7:30 am Harvard Bioscience reports Q2; guides FY16
finance.yahoo.com - July 28 at 7:30 AM
finance.yahoo.com logoHarvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET
finance.yahoo.com - July 18 at 4:30 PM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - June 27 at 4:16 PM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
biz.yahoo.com - May 27 at 4:11 PM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 12-May-16 12:30pm GMT
finance.yahoo.com - May 12 at 10:50 AM
biz.yahoo.com logoQ4 2015 and Q1 2016 Harvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today
biz.yahoo.com - May 12 at 8:30 AM
biz.yahoo.com logoQ1 2016 Harvard Bioscience Inc Earnings Release - Before Market Open
biz.yahoo.com - May 12 at 7:07 AM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
biz.yahoo.com - May 12 at 6:24 AM

Social

Chart

Harvard Bioscience (HBIO) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff